Dopamine Inhibits the Aldosterone Response to Upright Posture*
- 1 July 1986
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 63 (1) , 197-201
- https://doi.org/10.1210/jcem-63-1-197
Abstract
Aldosterone secretion in man is stimulated by potassium, ACTH, and angiotensin II and is inhibited by dopamine (DA). In normal sodium-replete supine individuals, aldosterone secretion is under maximum tonic inhibition by DA. Dopaminergic control of aldosterone secretion is modified by dietary sodium depletion. To determine the physiological significance of dopaminergic inhibition of aldosterone secretion, we studied the effect of DA on the aldosterone response to upright posture. Twelve normal men were studied while eating an ad libitum sodium diet, and the effect of DA was determined in the supine and upright positions. Plasma aldosterone (PAC), plasma cortisol (F), plasma aldosterone-stimulating factor (ASF), PRA, and blood pressure were measured while the men were supine and after 4 h of upright posture during an infusion of 5% dextrose vehicle and during a DA infusion of 4.0 µg/kg-min. The men also were studied as a time control in the supine position while receiving vehicle or DA. PAC increased from a mean basal value of 20.4 ± 3.2 ng/dl (±SE) by 25.9 ± 5.1 ng/dl to a peak of 44.4 ± 2.4 ng/dl in response to upright posture during vehicle infusion. The PAC response to upright posture was reduced to 7.4 ± 1.8 ng/dl (P < 0.05) when DA was infused. The increase in PRA with upright posture was 3.7 ± 1.3 ng/ml-h during the vehicle infusion and 4.1 ± 1.1 ng/ml-h (P = NS) during the DA infusion. ASF, F, and blood pressure were not altered by upright posture and DA. PAC did not change in the six men infused with DA while supine. Therefore, DA inhibits upright aldosterone responses without affecting PRA, ASF, or F.Keywords
This publication has 17 references indexed in Scilit:
- Effect of Metoclopramide on the Secretion and Metabolism of Aldosterone in Man*Journal of Clinical Endocrinology & Metabolism, 1981
- Dopaminergic Modulation of Aldosterone Secretion Is Independent of Alterations in Renin Secretion*Endocrinology, 1980
- IN VIVO AND IN VITRO STUDIES ON THE EFFECT OF METOCLOPRAMIDE ON ALDOSTERONE SECRETIONClinical Endocrinology, 1980
- Tonic Dopaminergic Suppression of Plasma Aldosterone*Journal of Clinical Endocrinology & Metabolism, 1980
- Dopaminergic Inhibition of Metoclopramide-induced Aldosterone Secretion in ManJournal of Clinical Investigation, 1980
- Dopamine Inhibits Angiotensin-Stimulated Aldosterone Biosynthesis in Bovine Adrenal CellsJournal of Clinical Investigation, 1979
- Effects of Metoclopramide and Bromocriptine on the Renin-Angiotensin-Aldosterone System in ManJournal of Clinical Investigation, 1979
- BROMOCRIPTINE: LACK OF EFFECT ON THE ANGIOTENSIN II AND ALDOSTERONE RESPONSES TO SODIUM DEPRIVATIONClinical Endocrinology, 1978
- METOCLOPRAMIDE INCREASES PLASMA ALDOSTERGNE CONCENTRATION IN MANJournal of Clinical Endocrinology & Metabolism, 1977
- Metoclopramide and dopamine receptor blockadeNeuropharmacology, 1976